Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Adipose Tissue

Explore clinical trials studying Neoplasms, Adipose Tissue. Study availability and eligibility vary by location and protocol.

167 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Adipose Tissue trial results

Recruiting

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

NCT06975293

Conditions
Dedifferentiated Liposarcoma, Leiomyosarcoma, Liposarcoma, +7 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Northwell Health Cancer Institute Lake Success, New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

NCT06881992

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +29 more
Locations
  • Investigative Site Chicago, Illinois, United States
  • Investigative Site Bethesda, Maryland, United States
  • Investigative Site Boston, Massachusetts, United States
  • Investigative Site Rochester, Minnesota, United States
View all 13 locations
View Trial Details
Recruiting

A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

NCT07089992

Conditions
Liposarcoma, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

NCT07377747

Conditions
Liposarcoma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • OSU James Hospital Columbus, Ohio, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View all 13 locations
View Trial Details
Recruiting

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

NCT06789172

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +49 more
Locations
  • Precision NextGen Oncology and Research Center Beverly Hills, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Chris O'Brien Lifehouse Sydney, New South Wales, Australia
View Trial Details
Recruiting

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

NCT05492682

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +44 more
Locations
  • Krankenhaus Nordwest Frankfurt, Germany
  • National Center for Tumor Diseases Heidelberg, Germany
  • Universitätsklinikum Tübingen Tübingen, Germany
  • Istituto di Candiolo Fondazione del Piemonte per l'oncologia IRCCS Candiolo, Italy
View Trial Details

Related conditions